FTC argues against proposed antitrust exemption for independent community pharmacies in Congressional testimony
The Federal Trade Commission testified on a proposed antitrust exemption for independent pharmacies before the U.S. House Judiciary Committee’s Subcommittee on Intellectual Property, Competition, and the Internet. H.R. 1946, “Preserving Our Hometown Independent Pharmacies Act of 2011,” would allow community pharmacies to engage in collective bargaining for higher fees and better contract terms from health plans.
The FTC argued that the exemption would lead to diminished competition and innovation. The decreased competition would then lead to price increases in health care–health plans would have to pay higher drug dispensing fees to pharmacists that would then be passed on to consumers.
Full content: FTC Press Release
Related content: Competition Come Full Circle? Pending Legislation to Repeal the U.S. Railroad Exemptions (Chris Sagers, Cleveland-Marshall School of Law)
Featured News
CVS Health Explores Potential Breakup Amid Investor Pressure: Report
Oct 3, 2024 by
CPI
DirecTV Acquires Dish TV, Creating 20 Million-Subscriber Powerhouse
Oct 3, 2024 by
CPI
South Korea Fines Kakao Mobility $54.8 Million for Anti-Competitive Practices
Oct 3, 2024 by
CPI
Google Offers Settlement in India’s Antitrust Case Regarding Smart TVs
Oct 3, 2024 by
CPI
Attorney Challenges NCAA’s $2.78 Billion Settlement in Landmark Antitrust Cases
Oct 3, 2024 by
nhoch@pymnts.com
Antitrust Mix by CPI
Antitrust Chronicle® – Refusal to Deal
Sep 27, 2024 by
CPI
Antitrust’s Refusal-to-Deal Doctrine: The Emperor Has No Clothes
Sep 27, 2024 by
Erik Hovenkamp
Why All Antitrust Claims are Refusal to Deal Claims and What that Means for Policy
Sep 27, 2024 by
Ramsi Woodcock
The Aspen Misadventure
Sep 27, 2024 by
Roger Blair & Holly P. Stidham
Refusal to Deal in Antitrust Law: Evolving Jurisprudence and Business Justifications in the Align Technology Case
Sep 27, 2024 by
Timothy Hsieh